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Background: Diamond–Blackfan anemia is a rare congenital red blood cell dysplasia that develops soon after birth.
RPL11 mutations account for approximately 4.8% of human DBA cases with defective hematopoietic phenotypes.
However, the mechanisms by which RPL11 regulates hematopoiesis in DBA remain elusive. In this study, we
analyzed the transcriptome using deep sequencing data from an Rpl11-deficient zebrafish model to identify
Rpl11-mediated hematopoietic failure and investigate the underlying mechanisms.
Results: We characterized hematological defects in Rpl11-deficient zebrafish embryos by identifying affected
hematological genes, hematopoiesis-associated pathways, and regulatory networks. We found that hemoglobin
biosynthetic and hematological defects in Rpl11-deficient zebrafish were related to dysregulation of iron
metabolism-related genes, including tfa, tfr1b, alas2 and slc25a37, which are involved in heme and hemoglobin
biosynthesis. In addition, we found reduced expression of the hematopoietic stem cells (HSC) marker cmyb and
HSC transcription factors tal1 and hoxb4a in Rpl11-deficient zebrafish embryos, indicating that the hematopoietic
defects may be related to impaired HSC formation, differentiation, and proliferation. However, Rpl11 deficiency did
not affect the development of other blood cell lineages such as granulocytes and myelocytes.
Conclusion: We identified hematopoietic failure of Rpl11-deficient zebrafish embryos using transcriptome deep
sequencing and elucidated potential underlying mechanisms. The present analyses demonstrate that Rpl11-deficient
zebrafish may serve as a model of DBA and may provide insights into the pathogenesis of mutant RPL11-mediated
human DBA disease.
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Ribosomal protein dysfunction causes abnormal ribosomal
particle assembly and affects protein synthesis in all cell
types. Although RP dysfunction affects multiple tissues
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reproduction in any medium, provided the oranemia (DBA), are the most frequently observed pheno-
types [1-3].
Mutations in RP genes reduce the efficiency of ribosome
biogenesis, which is indispensable for immature erythro-
cytes in early and rapid growth phases [4]. Defective ribo-
some biosynthesis leads to excessive release of RPs such as
RPL5 and RPL11, which may increase p53 activity by acti-
vating the RPS MDM2-p53 signaling pathway [5]. Because
erythroid progenitor cells are highly sensitive to p53 acti-
vation [6], subsequent activation of the p53 pathway in
erythroid progenitor cells leads to cell cycle arrest and
apoptosis and finally to hematopoietic disorders. Interest-
ingly, these hematopoietic defects were rescued by in-
creased RP expression or reduced p53 activity in zebrafishLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[7-10]. It was also observed that Rpl22l1 plays essential
roles in hematopoiesis, but acts independently of p53 and
does not induce apoptosis [11].
DBA is a rare congenital red blood cell dysplasia that
develops soon after birth. This disorder is mainly charac-
terized by reduced reticulocyte counts, selective red cell
aplasia, and macrocytosis, while a number of other blood
cell lineages, such as neutrophils and platelets, are main-
tained or slightly decreased. Furthermore, DBA patients
suffer other developmental defects, such as short stature,
cleft lip, hand deformities, kidney and heart hypoplasia,
and tumor predisposition [12-14]. Ribosome biogenesis
defects have been identified as a major cause of DBA,
and mutations of genes encoding RPs have emerged as
the main cause of DBA. Indeed, various mutations have
been found in coding and noncoding regions of at least
13 RPs, including RPL5, RPS7, RPL9, RPS10, RPL11,
RPS15, RPS17, RPS19, RPS24, RPS26, RPL36, RPS27a,
and RPL35a, accounting for about 55% of all DBA cases
[15-23]. RPS19 was the first identified causative gene in
DBA patients, and its mutations account for 25% of
DBA cases [24].
RPL11 is one of 79 vertebrate RPs, and its gene muta-
tions occur on coding and intronic binding regions of
chromosome 1 [17]. DBA patients with mutations in
RPL11 show typical hematopoietic defects, and 67% of
these have physical deformities, especially of the thumb
[17]. In particular, RPL11 dysfunction results in abnormal
erythrocyte development, markedly decreased progenitor
cell proliferation, delayed erythroid differentiation, and
markedly increased apoptosis [25]. Importantly, these are
different from the deficiencies in DBA patients with
RPS19 mutations [25]. Hence, divergent mechanisms
underlie hematopoietic defects in DBA patients with
different RP mutations. Moreover, RPL11 dysfunction in
erythroblasts lead to aberrant erythroblast differentiation,
reduced hemoglobin, and unusual cell morphology [26].
Zebrafish are a classic animal model for mechanistic
studies of embryonic development, hematopoiesis, and
DBA [27,28]. Knockdown of most RP genes causes devel-
opmental defects in the brain of zebrafish, indicating that
the vast majority of RP functions are associated with ner-
vous system development [29]. Several reports focus on
regulation of zebrafish hematopoiesis by the RP proteins
Rps7, Rpl11, Rps19, and Rps29 [8-10,30]. Rpl11 dysfunc-
tion in zebrafish embryos leads to defective development,
hematopoiesis, brain development, and shape dysplasia
[8,29,31]. Furthermore, Danilova et al. reported that the
hematopoietic defects caused by Rpl11 dysfunction were
fully reversed by the inhibition of p53 activity in zebrafish
mutants [8], indicating that p53 may regulate Rpl11 in zeb-
rafish [25,31]. However, hematopoiesis in zebrafish with
dysfunctional Rps19 is not fully recovered by inhibition ofp53 [32]. Presumably, these varying phenotypic defects in
zebrafish embryos with dysfunctional Rpl11 are regulated
by multifactorial interactions of genes, regulatory networks,
and signaling pathways.
High-throughput transcriptome sequencing is now
widely accepted as a useful tool for investigating human
disease mechanisms and gene functions. However, this
technology has not been widely used in zebrafish research.
Using microarray technology, Danilova et al. (2011) stud-
ied the impact of Rpl11 deficiency on hematopoiesis of
zebrafish embryos. However, because of the limitations of
detectable gene transcripts, some important aspects of
Rpl11 functions in zebrafish may only be elucidated using
high-throughput sequencing.
In this study, we examined genome-wide transcription by
high-throughput transcriptome sequencing of Rpl11-deficient
zebrafish embryos. In combination with bioinformatic
analyses, we studied affected genes, hematopoiesis-related
signaling pathways, and molecular regulatory networks in
Rpl11-deficient zebrafish embryos. We found that Rpl11
deficiency leads to defects of hemoglobin synthesis and
hematopoiesis, which were caused by dysregulation of
iron metabolism-related genes and impaired HSC differ-
entiation and proliferation. These analyses provide new in-
sights into the pathogenesis of mutant Rpl11-mediated
DBA.
Results
Hematopoietic defects in Rpl11-deficient zebrafish
embryos
To investigate the regulation of Rpl11 in hematopoiesis in
zebrafish embryos, we initially established an Rpl11-
deficient zebrafish model using MO knockdown technology.
We observed various phenotypes in this model, including
smaller brains, tail deformities, and hematopoietic defects,
which were consistent with other studies [8,29,31]. Benzi-
dine staining of Rpl11-deficient zebrafish embryos at 48
hpf showed that globin expression was significantly de-
creased compared with that in control MO embryos, indi-
cating defects of globin synthesis during late erythroid
differentiation (Figure 1A–D). Subsequently, deep sequen-
cing was performed to investigate the impact of Rpl11 on
the transcriptome of Rpl11-deficient and control MO em-
bryos at 48 hpf. The effectiveness of translational inhib-
ition by Rpl11 MO was confirmed by examining the green
fluorescent fusion protein under a fluorescence micro-
scope (Figure 1E–F).
Transcriptome changes in Rpl11-deficient zebrafish
embryos
To comprehensively reflect the impact of Rpl11 deficiency
on the transcriptome of zebrafish embryos, we collected
40–50 Rpl11-deficient and MO control zebrafish embryos
















Figure 1 Benzidine staining of Rpl11-deficient zebrafish embryos and the effectiveness of translational inhibition by Rpl11 MO.
(A, B, C, D), O-staining shows markedly reduced numbers of hemoglobin-stained blood cells in Rpl11-knockdown embryos; (E, F), The Rpl11–egfp
construct was assembled by inserting a partial sequence of Rpl11 cDNA (containing 60 bps from the 5′ UTR) and the N-terminus of egfp into modified
pEGFP-N1 (the ATG codon of EGFP was removed). The sequence of Rpl11 MO1 compliments 1–24 bp of Rpl11 cDNA. Embryos co-injected with 25 ng
Rpl11–EGFP DNA and 0.5 ng control MO expressed EGFP, and Rpl11–EGFP expression was inhibited by co-injection with 0.5 ng Rpl11 MO; B, D, E, and F
are the lateral view; A and C are the ventral view.
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lel. High-throughput sequencing was performed on the
Hi-Seq2000 sequencing platform in parallel. The number
of sequenced gene transcript reads was 35–40 million.
Sequencing data were mapped to the latest Zv9 version of
the zebrafish genome. Subsequently, 15–17 million read-
able gene transcripts were mapped to the zebrafish gen-
ome with 41–45% mapping efficiency (Additional file 1:
Table S1). On average, more than 10,000 gene transcripts
were mapped to known zebrafish genes, accounting for at
least 70% of annotated genes. The percentage of detected
unique gene transcripts was similar to that detected in
previous studies [33,34], indicating that the present se-
quencing represented the vast majority of zebrafish genes.
All sequenced gene transcript reads were standard-
ized to FPKM [35], and gene expression was presented
(Additional file 2: Table S2). The R package DEGseq
was used to compare transcriptomes of Rpl11-deficient
zebrafish embryos and MO control embryos. In total,
we identified 572 significantly differentially expressed
genes (DEGs, FC >2, p-value <0.05); 483 were downreg-
ulated and 89 were upregulated. We also identified
DEGs using screening thresholds set at p-value <0.05 and
FC >1.5 (Additional file 3: Table S3). In addition, we found
10 specifically expressed genes (p-value <0.05) that wereonly expressed in one sample (Additional file 4: Table S4).
Among these, four were significantly upregulated in
Rpl11-deficient zebrafish embryos, whereas expression of
the other six was almost completely inhibited, indicating
high dependence of gene expression on Rpl11.
Gene ontology analysis of Rpl11 in zebrafish embryos
To investigate the biological functions of Rpl11 in zebra-
fish embryos, we performed GO analyses of genes that
were significantly regulated by Rpl11 deficiency using
AmiGO software (http://www.geneontology.org/). Since
IPA software does not contain the zebrafish gene anno-
tation that must be transformed into human genes be-
fore analysis, we used the GO analysis tool in the ZFIN
database to get more detailed information of Rpl11 func-
tions in zebrafish. GO analyses showed that upregulated
genes were specifically enriched in functions associated
with iron metabolism, including iron transport, intracellu-
lar iron homeostasis, and iron binding (Additional file 5:
Figure S1 and Additional file 6: Table S5). Three zeb-
rafish genes were involved in these iron-related func-
tions, including zgc:194125, zgc:109934, and zgc:173594
(Additional file 7: Figure S3). However, no detailed gene
annotations exist in the latest version (Zv9) of the zebra-
fish genome. Interestingly, a single human mitochondrial
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zebrafish genes, and its aberrant expression resulted in ac-
cumulation of mitochondrial iron, disruption of intracellu-
lar iron homeostasis [36], and reduction in iron utilization
for heme and hemoglobin synthesis [37]. Downregulated
genes were specifically enriched in functions associated
with development and differentiation of the nervous sys-
tem, generation of neurons and brain development, mo-
lecular metabolic regulation, developmental regulation of
cells and tissues, regulation of gene transcription, regula-
tion of RNA synthesis and metabolism, and other func-
tions (Additional file 5: Figure S2 and Additional file 6:
Table S5). Thus, GO analyses demonstrated that Rpl11 par-
ticipates in the regulation of multiple biological processes
in zebrafish embryos, and particularly in hematopoietic
iron metabolism-associated pathways.
Hematological genes affected by Rpl11 deficiency in
zebrafish embryos
To further investigate hematopoietic failures caused by
Rpl11 deficiency in zebrafish, we analyzed affected hema-
tological genes in Rpl11-deficient zebrafish embryos at
48 hpf. To provide a more detailed list of hematological
genes affected by Rpl11 deficiency, the screening criteria
were set at FC >1.5 and p-value <0.05. In total, 33 differ-
entially expressed hematological genes were identified
(Additional file 8: Figure S4), and description of these genes
were summarized in Table 1. Heatmap analyses showed
that most (24/33) hematological genes were significantly
downregulated by Rpl11 deficiency (Figure 2A). Subsequent
GO analyses demonstrated that these hematological
genes were specifically enriched in diverse hematopoiesis-
associated biological processes, including oxidation–
reduction processes, heme binding, hypoxic oxygen
binding, oxygen transporter activity, iron transport, and
oxygen transport (Figure 2B). Hematological genes in-
volved in GO items were summarized in (Additional file 9:
Table S6).
Identification of hematopoiesis-associated pathways
disturbed in Rpl11-deficient zebrafish
Key signaling pathways in mammals are highly con-
served in zebrafish. To elucidate the roles of Rpl11 in
the regulation of hematopoiesis in zebrafish embryos, we
used IPA software to identify the signaling pathways that
are most affected (p-value <0.01) by Rpl11 deficiency.
Separate pathways were constructed with upregulated
and downregulated genes (Additional file 10: Table S7).
Among the five most affected signaling pathways, we
identified three hematopoiesis pathways that were up-
regulated, including glucocorticoid receptor signaling
[38,39], IGF-1 signaling [40-42], and IL-17A signaling in
fibroblasts [43], and two hematopoiesis-related pathways
that were downregulated, including Wnt/β-catenin sig-naling [44-48] and Aryl hydrocarbon receptor signaling
[49] (Table 2). Among these pathways, Wnt/β-catenin
signaling has been characterized as essential for forma-
tion, self-renewal, and development of hematopoietic
stem cells (HSCs) [48], which are closely associated
with hematopoiesis. Taken together, Rpl11 deficiency
disturbed hematopoiesis-related signaling pathways in
zebrafish embryos, at least partially explaining the ensuing
hematopoietic failure.
Identification of regulatory networks affected by Rpl11
deficiency in zebrafish embryos
We used IPA software to determine whether molecular
regulatory networks were disturbed by Rpl11 deficiency
in zebrafish embryos (Additional file 11: Figure S5A-C,
Figure S6A-E, and Additional file 12: Table S8). Analyses
showed no specifically enriched hematopoiesis-associated
regulatory networks of differentially regulated genes.
Potentially, hematopoiesis-associated networks may
have been weakened by more important functions of
Rpl11 in zebrafish embryos and were therefore not
detectable or were obscured by networks regulating
hematopoiesis by unknown mechanisms. Through these
networks, Rpl11 may play critical regulatory roles in cell
development, proliferation, and apoptosis, nervous sys-
tem development, embryonic development, immuno-
logical disease, and tumor pathology. We also identified
central network nodes that may directly or indirectly as-
sociate with RPL11, including MMP9, AP1, SERPINE1,
CTGF, FOS, JUNB, SOCS3, SOX2, TWIST1, CCND1,
MMP2, and APP.
Potential mechanisms through which Rpl11 regulates
hematopoiesis in zebrafish embryos
Benzidine staining of Rpl11-deficient zebrafish embryos
showed that hemoglobin biosynthesis was significantly
diminished, suggesting defects in hemoglobinization and
late erythroid differentiation, which are consistent with
the hypochromic anemia typical of iron, heme, or globin
deficit in zebrafish embryos [50]. Focusing on the genes
associated with erythrocyte iron metabolism, we found
that the majority of genes involved in zebrafish iron me-
tabolism were abnormally expressed (Table 3). These in-
cluded alas2, cp, fth1a/b, htt, aco2, slc25a37, sfxn1, tfa,
and tfr1b, suggesting that Rpl11 deficiency in zebrafish
might affect multiple aspects of iron metabolism that are
closely regulated in highly hemoglobinized erythrocytes.
For example, reduced expression of tfa and tfr1b tran-
scripts indicates damaged iron acquisition by erythro-
cytes and that of slc25a37 and alas2 indicates aberrant
iron utilization by erythrocytes (Figure 3A). Moreover,
upregulation of three homologs of human FTMT in
Rpl11-deficient zebrafish embryos, including zgc:194125,
zgc:109934, and zgc:173594 (Additional file 7: Figure S3),
Table 1 Affected hematological genes in Rpl11-deficient zebrafish embryos at 48 hpf
Genes Fold change p-Value Description Human homolog
hbbe3 ↑3.12 0 Hemoglobin beta embryonic-3 HBE1
hbbe2 ↑1.56 3.84E-23 Hemoglobin beta embryonic-2 HBE1
zgc:153284 ↑2.32 6.20E-13 zgc:153284 -
cyp26a1 ↑3.13 0.001089 Cytochrome P450, subfamily XXVIA, polypeptide 1 CYP26A1
ddx18 ↑1.58 0.003224 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 DDX18
cyp24a1 ↑6.16 0.014658 Cytochrome P450, family 24, subfamily A, polypeptide 1 CYP24A1
ptgs2a ↑2.21 0.023441 Prostaglandin-endoperoxide synthase 2a -
zgc:56493 ↓1.63 2.38E-18 zgc:56493 TXN
cox4i1 ↓1.52 6.39E-17 Cytochrome c oxidase subunit IV isoform 1 COX4I1
pdia3 ↓2.94 1.45E-13 Protein disulfide isomerase family A, member 3 PDIA3
pdia4 ↓3.75 7.23E-10 Protein disulfide isomerase associated 4 PDIA4
hdac1 ↓1.68 8.99E-08 Histone deacetylase 1 HDAC1
Cat ↓3.66 2.19E-06 Catalase CAT
rrm2 ↓2.04 1.47E-05 Ribonucleotide reductase M2 polypeptide -
p4hb ↓2.02 2.57E-05 Procollagen-proline, 2-oxoglutarate 4-dioxygenase, beta polypeptide P4HB
rrm1 ↓1.82 3.28E-05 Ribonucleotide reductase M1 polypeptide RRM1
cyp2aa8 ↓2.29 0.000119 cytochrome P450, family 2, subfamily AA, polypeptide 8 -
tp53 ↓1.66 0.000172 Tumor protein p53 TP53
agxt2l1 ↓4.63 0.000349 Alanine-glyoxylate aminotransferase 2-like 1 AGXT2L1
pdip5 ↓2.06 0.000366 Protein disulfide isomerase-related protein (provisional) PDIA6
alas2 ↓1.60 0.000435 Aminolevulinate, delta-, synthetase 2 ALAS2
Max ↓1.88 0.000645 myc-associated factor X MAX
isca1 ↓1.72 0.000755 Iron-sulfur cluster assembly 1 ISCA1
sh3bgrl3 ↓2.39 0.002398 SH3 domain binding glutamic acid-rich protein like 3 SH3BGRL3
pgrmc1 ↓1.86 0.003269 Progesterone receptor membrane component 1 PGRMC1
snrnp70 ↓1.76 0.006001 Small nuclear ribonucleoprotein 70 (U1) SNRNP70
cyp2aa4 ↓2.27 0.007172 Cytochrome P450, family 2, subfamily AA, polypeptide 4 -
mta2 ↓1.62 0.009737 Metastasis associated 1 family, member 2 MTA2
sema3d ↓4.42 0.016997 Semaphorin 3d SEMA3D
txndc5 ↓1.53 0.029683 Thioredoxin domain containing 5 TXNDC5
Mb ↓2.85 0.037113 Myoglobin MB
slc40a1 ↓1.96 0.037939 Solute carrier family 40 (iron-regulated transporter), member 1 SLC40A1
pgrmc2 ↓1.63 0.038689 Progesterone receptor membrane component 2 PGRMC2
Differentially expressed hematological genes in Rpl11-deficient zebrafish embryos were identified (Fold change >1.5, p-value <0.05).
Zhang et al. BMC Genomics 2013, 14:896 Page 5 of 14
http://www.biomedcentral.com/1471-2164/14/896could lead to imbalances in cytoplasmic and mitochon-
drial iron metabolism in erythrocytes [37]. At present, it
is widely reported that dysfunction of these genes in ani-
mal models leads to hematopoiesis-associated diseases
such as siderocytic and microcytic anemia (Table 3).
Taken together, aberrant expression of these genes may
seriously damage iron metabolism, iron supply for heme
biosynthesis, and hemoglobin biosynthesis during late
erythroid differentiation, finally resulting in defective
hematopoiesis in zebrafish embryo.HSCs are capable of self-renewal and have the poten-
tial to differentiate into all blood cell lineages, including
erythrocytes. Runt-related transcription factor 1 (Runx1)
was previously shown to be necessary for formation of
HSCs. However, mRNA expression of runx1 was too low
(FPKM <1) to represent its actual expression in zebrafish
embryos using RNA-Seq data. Thus, we assessed the
proliferation and differentiation of HSCs in Rpl11-
deficient zebrafish embryos by observing the expression
of the HSC marker cmyb. As shown in Figure 3B and
Figure 2 Analysis of affected hematological genes in Rpl11-deficient zebrafish embryos at 48 hpf. A, Cluster analysis of affected
hematological genes. A total of 33 hematological genes exhibited changed expression in Rpl11-deficient zebrafish embryos at 48 hpf (FC >1.5,
p-value <0.05). Hematological genes were clustered in upregulated and downregulated groups, and most affected hematopoietic genes were
downregulated in Rpl11-deficient zebrafish embryos at 48 hpf; B, Gene ontology (GO) enrichment of affected hematological genes in Rpl11-
deficient zebrafish embryos at 48 hpf. Among hematological genes, the largest three fractions represented oxidoreductase activity, cytoplasmic
component, and electron carrier activity. Hematological genes with iron metabolism-associated functions such as heme and iron binding were
also enriched.
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decrease in the mRNA expression of cmyb, indicating
reduction in HSCs in Rpl11-deficient zebrafish embryos.
In addition, we observed dramatic reductions in mRNA
expression of HSC transcription factors, including
hoxb4a, which regulates HSC expansion [63], and tal1,
which controls differentiation and development of HSCs
[64]. Given occasional dysplasia of blood cell lineages
other than erythrocytes in DBA patients, we determined
whether Rpl11 deficiency affected the development and
proliferation of granulocytes, lymphocytes, and myelo-
cytes by observing the cellular markers ikzf1, spi1, and
mpx, respectively. qPCR analyses showed no changes in
expression of these markers in Rpl11-deficient zebrafish
embryos (Figure 3B), suggesting that development and
proliferation of lymphocytes, myelocytes, and granulo-
cytes were unaffected by Rpl11 deficiency. Taken to-
gether, hematopoietic failure in Rpl11-deficient zebrafish
may be attributed to defective erythropoiesis in zebrafish
embryo HSCs.
Discussion
P53 pathway acts independently of Rpl11-deficiency in
zebrafish embryos
In previous studies, hematopoiesis was sensitive to p53
activation [6], and p53 pathway was shown to be
activated in DBA patients [25,65] and in RP-deficientzebrafish with defective hematopoiesis [9,10,30]. How-
ever, we did not observe upregulation of p53 signaling
in Rpl11-deficient zebrafish embryos. Potentially slight
changes in expression of p53-related genes were obscured
by more marked transcriptional consequences of Rpl11
deficiency in zebrafish embryos. However, these observa-
tions are consistent with RPL11-independent activation of
the p53 pathway in DBA patients [25]. In addition, p53 ex-
pression was decreased in tumor cells with dysfunctional
RPs [66], suggesting that p53 expression may be sensitive
to tumor and tissue environments. Consistent with cells of
DBA patients, we speculate that cells of Rpl11-deficient
zebrafish embryos may carry characteristics of tumor
cells [13,17,67].
It remains unclear whether the entire hematopoietic
defective phenotype of DBA is associated with increased
expression of p53 or p53-independent mechanisms [25].
Indeed, in a recent report, dysfunctional Rpl22 and
Rpl22l1 led to blockage of HSC emergence. Although
Rpl22l1 plays essential roles in hematopoiesis, it did not
induce apoptosis and acted independently of p53 [11]. In
this study, we tested the effects of p53 on phenotypes of
Rpl11-deficient zebrafish embryos by observing changes
in the expression of the HSC formation marker cmyb in
Rpl11 morphants and Rpl11 and p53 in double mor-
phants at 48 hpf. In these experiments, decreased cmyb
expression was not significantly rescued by p53 MO at
Table 2 Affected hematopoiesis-associated signaling pathways in Rpl11-deficient zebrafish embryos at 48 hpf
Ingenuity canonical pathways -log (p-value) Up/down regulation Functions Reference
Wnt/β-catenin signaling 3.81E + 00 Down HSC formation, self-renewal, and differentiation [44-48]
Aryl hydrocarbon receptor signaling 3.70E + 00 Down Maintenance of HSC quiescence [49]
IGF-1 signaling 4.28E + 00 Up Regulation of hematopoiesis and proliferation of
hematopoietic stem cell progenitor cells
[40-42]
IL-17A signaling in fibroblasts 4.27E + 00 Up Linking T cell function and hematopoiesis, mediating
the hematopoietic response
[43]
Glucocorticoid receptor signaling 3.67E + 00 Up Stimulation of BFU-E progenitor self-renewal
and regulation of stress erythropoiesis
[38,39]
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addition, we also tested the effects of p53 on defective
hematopoietic phenotypes of Rpl11-deficient zebrafish
embryos by performing hemoglobin staining of embryos
injected with Rpl11 MO and Rps19 MO, both individually
and with coinjections of p53 MO. O-staining showed a
significant reduction in the number of hemoglobin stained
blood cells in individual Rpl11 or Rps19 knockdowns. The
Rps19 MO phenotype was partially rescued by coinjection
with p53 MO, whereas the Rpl11 MO phenotype was not
(Figure 4D-I). Taken together, these results demonstrated
that Rpl11 leads to hematopoietic defects in zebrafish
embryos through p53-independent pathways.
Hemoglobin genes’ translation could be inhibited in
Rpl11-deficient zebrafish embryos
We observed markedly reduced hemoglobin expression in
Rpl11-deficient zebrafish embryos and analyzed globin
expression using RT-PCR analysis data (Additional file 14:
Figure S7). In total, we identified six globin transcriptsTable 3 Summary of affected iron metabolism-related genes
Zebrafish gene Fold change Functions
alas2 ↓1.44 First enzyme of heme synthesis
tfa ↓1.89 Fe(III)-carrier in plasma
tfr1b ↓2.75 Membrane receptor for Fe(II)-TF
aco2 ↓1.3 Bind to IREs; Fe sensors
fth1a ↓1.35 Prevents Fe toxicity during erythropoiesis
fth1b ↓1.83
slc25a37 ↓1.77 Iron transport into mitochondria
cp ↓2.88 Oxidizes exported Fe2+
htt ↓1.27 Transferrin receptor trafficking
sfxn1 ↓2.19 Mitochondrial transport and iron metabol
zgc:194125 ↑2.73 Iron homeostasis and heme synthesis
zgc:109934 ↑2.36
zgc:173594 ↑4.12
The arrow up and down respectively stand for up- and down-regulation of genes inhbaa1, hbae1, hbae3, hbbe1, hbbe2, and hbbe3 in zebrafish
embryos at 48 hpf in RNA-Seq data. Among these, hbae1,
hbae3, hbbe1, and hbbe3 are specifically expressed in
embryos, while hbbe2 and hbaa1 are specifically expressed
in larvae and adults, respectively [68]. Quantitative PCR
analyses demonstrated decreased hbaa1 and hbbe1 ex-
pression, but increased hbae1, hbae3, hbbe2, and hbbe3
expression to varying degrees (Additional file 14: Figure
S7). Given the reduced availability of heme and iron in
Rpl11-deficient zebrafish, we deduced that translation of
globins might depend on the availability of heme [69]. Be-
cause RPL11 deficiency specifically impairs the translation
of erythroid genes in murine and human erythroblasts
[26], we hypothesized that Rpl11 may specifically inhibit
erythroid-specific globin translation in zebrafish embryos.
Dysfunction of iron- and heme-metabolism related genes
in Rpl11-deficient zebrafish
Erythrocyte hemoglobinization involves upregulation




X-linked sideroblastic anemia ALAS2 [51]




Microcytic anemia IRP2 [54]
Embryonic lethality FTH1 [55,56]
Embryonic lethal with profound
anemia; hypochromic anemia
SLC25A37 [57,58]
Hypochromic microcytic anemia CP [59]
Hypochromic anemia HTT [60]
ism Siderocytic anemia SFXN1 [61]
Sideroblastic anemia FTMT [37,62]
Rpl11-deficient zebrafish embryos.
Figure 3 qPCR analysis of changes in the expression of genes potentially associated with hematological defects in Rpl11-deficient
zebrafish embryos. A, Analysis of changes in expression of genes associated with iron and heme metabolism in Rpl11-deficient zebrafish
embryos; B, Analysis of changes in expression of molecular blood cell lineage markers. Gene expression was represented as mean ± SD and
One-way ANOVA was performed for comparison between MO control and Rpl11-deficient embryos (***P < 0.001, **P < 0.01, * < 0.05, n = 3). Gene
expression in MO control samples was normalized to 1.
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deficient zebrafish, the vast majority of iron and heme
metabolism-related genes were downregulated, contribut-
ing significantly to defective hemoglobinization and
hematopoiesis. Hematopoiesis requires large amounts of
iron. In serum, most iron is bound to transferrin (Tf; tfa in
zebrafish), which directs iron to hemoglobin via transfer-
rin receptor (TfR1; tfr1b in zebrafish)-mediated endocyto-
sis [70,71]. TfR1 (tfr1b) is highly expressed in erythrocytes
and is directly associated with hemoglobin synthesis and
erythroid progenitor maturation [71,72]. On binding, the
Fe(III)–transferrin–TfR1 complex is rapidly internalized,
and iron atoms are released and directed to the mitochon-
dria for heme synthesis [70,71]. The mitochondrial iron
transporter SLC25A37 (slc25a37 in zebrafish) is also
highly expressed in erythrocytes, and its activity has been
shown to be rate limiting for heme synthesis in erythro-
cytes [57,58]. Moreover, deficiency of the Drosophila
homolog mfrn causes a 90% decrease in heme synthesis,
and knockout of Slc25a37 in mice leads to embryoniclethality with profound anemia [58]. Zebrafish with the
mutant slc25a37 show severe hypochromic anemia due to
defective mitochondrial iron uptake [57]. ALAS2 is an
erythroid-specific rate-limiting enzyme responsible for
synthesis of protoporphyrin IX, which is transported out
of the mitochondria and installed in globin chains for
hemoglobin biosynthesis [73]. Indeed, mutations of Alas2
in mice caused sideroblastic anemia [51]. Finally, FTMT
was not expressed in normal erythroblasts but was highly
expressed in patients with sideroblastic anemia [62]. Up-
regulation of FTMT results in accumulation of mitochon-
drial iron followed by disruption of intracellular iron
homeostasis [36]. Moreover, overexpression of FTMT
limits the availability of iron for heme synthesis and
impairs mitochondrial iron metabolism [37]. We also ob-
served increased expression of the putative zebrafish
FTMT homologs zgc:194125, zgc:109934, and zgc:173594
in Rpl11-deficient zebrafish embryos, further indicating
hematopoiesis-associated disease exists in Rpl11-deficient



















Figure 4 Rpl11 deficiency is required for hematopoietic defects through p53-independent pathways in zebrafish embryos. A-C, Rpl11 is
required for HSC formation through p53-independent pathways. The expression of cmyb was significantly decreased in Rpl11 morphants and in
Rpl11 and p53 double morphants at 48 hpf compared with that in control embryos. D-I, Rpl11 deficiency caused defective hematopoietic pheno-
types in zebrafish embryos through p53-independent pathways. Hemoglobin staining of embryos individually injected with Rpl11 MO or Rps19
MO and coinjected with p53 MO were performed. D and G are controls, E and H are Rpl11 MO or Rps19 knockdown, and F and I are Rpl11 MO
and Rps19 MO coinjected with p53 MO, respectively. Panel A–C, lateral views; D-I, ventral views.
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tor of iron and heme metabolism.
Rpl11-deficient zebrafish could serve as a human DBA
model
RPL11 gene mutation leads to disease phenotypes of hu-
man DBA, including hematopoietic defects and physical
deformities [18]. In zebrafish, Rpl11 deficiency leads to
hematopoietic and metabolic defects [8] as well as brain
developmental abnormalities [31]. Zebrafish with dys-
functional RPs have been regarded as suitable animal
models for DBA studies [30]. Using the Rpl11-deficient
zebrafish model and transcriptome deep sequencing, we
have added crucial details to the understanding of the
biological functions of Rpl11 in zebrafish and have eluci-
dated potential mechanisms by which Rpl11 regulates
hematopoiesis. Future studies will determine which
pathways and regulatory mechanisms are common to
both human DBAs and this zebrafish model. Zebrafish
may serve as model systems for human diseases, and
hence, our findings provide an important resource and
shed new insights for the study of human DBA diseases.
Conclusion
In this study, we established an Rpl11-deficient zebrafish
model that showed defective hemoglobinization and he-
matopoiesis. To elucidate the mechanisms of hematopoieticfailure, we performed mRNA transcriptome deep sequen-
cing of Rpl11-deficient and control MO zebrafish embryos
and systematically characterized Rpl11-mediated distur-
bances in hematological gene expression, hematopoiesis-
related signaling pathways, and regulatory networks in
zebrafish. We also elucidated potential mechanisms by
which Rpl11 regulates hematopoiesis through genes
associated with iron metabolism and proliferation and
development of HSCs in zebrafish embryos or through
hematopoiesis-associated pathways with unknown me-
chanisms (Figure 5). The present data provide new
insights into the pathogenesis of RPL11-mediated DBA.
Methods
Zebrafish embryo maintenance, Rpl11 morpholino (MO)
microinjection, and hemoglobin staining
Wild-type zebrafish (Danio rerio; AB type) were main-
tained under standard library conditions and zebrafish em-
bryo stages (hours post fertilization; hpf) were determined
as described previously [74,75]. All studies of zebrafish
were approved by the Animal Care and Use Committee of
Huazhong University of Science and Technology. Rpl11
Morphlino (MO; 5-CTTCTTCTCGCTCTGGTCCGCCA
TG-3) and control MO (5-CTTATTCGCGCTATGGTC
GGCAATG-3) were obtained from Gene-Tools, LLC. The
Rps19 MO, p53 MO, and control MO were previously de-






Iron metabolism and heme 
synthesis defects 
Hemoglobin synthesis defects 
Abnormal expression of  alas2, 
tfa, and tfr1b… 
Disturbed hematopoiesis-
associated pathways 
Figure 5 Potential molecular mechanisms by which Rpl11 deficiency leads to hematopoietic defects in zebrafish embryos. In this study,
we deduced three potential mechanisms by which Rpl11 deficiency leads to hematopoietic defects in zebrafish embryos. First, Rpl11 deficiency
led to abnormal expression of a set of iron metabolism- and heme synthesis-related genes. Second, Rpl11 deficiency disturbed proliferation and
development of HSCs. Finally, Rpl11 deficiency disturbed several hematopoiesis-associated pathways. Solid lines represent mechanisms that have
been confirmed in this or other studies, and dashed lines represent mechanisms that require further validation.
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PV830). Based on the literature and our initial injection
trials, 0.5-ng Rpl11 MO and control MO were chosen as
the optimal concentration. The effectiveness of transla-
tional inhibition by this Rpl11 MO was tested in vivo
using a Rpl11–egfp green fluorescent fusion protein.
We found that at a dose of 0.5 ng/embryo, most GFP
expression was knocked down. Hemoglobin in zebrafish
embryos was analyzed using o-dianisidine (Sigma) as
described [77]. All images were collected using an
Olympus microscope with a digital camera (OLYMPUS
IX71) and were imported into Adobe Photoshop CS2
9.0.2 for orientation and figure preparation.
Total RNA isolation, library preparation, and sequencing
Immediately after harvesting, 40–50 pooled embryos at
48 hpf from at least three experiment were snap-frozen
in liquid nitrogen and stored at −80°C. Total RNA was
extracted from pooled embryos using TRIzol reagent
(Invitrogen) according to the manufacturer’s instruc-
tions. RNA concentrations were determined using Nano-
Drop 2000 (Thermo Scientific). The integrity of RNA
samples was determined using 1.2% agarose gel electro-
phoresis, followed by removal of the residual genomic
DNA with RNase-free DNase I (Ambion). Libraries of
mRNA were constructed using the Illumina mRNA-Seq
library preparation kit according to the manufacturer’s
instructions. Concentration and size distribution of the
libraries were determined on an Agilent Bioanalyzer
DNA 2000 chip (Agilent Technologies), followed by se-
quencing on an Illumina Hiseq 2000 Genome Analyser
platform in pair-end mode by 100-bp lengths. A total of
35–40 million reads were collected for further analysis.RNA-Seq data analysis
Reads were processed and aligned to the UCSC zebrafish
reference genome (build Zv9/danRer7, Jul. 2010) using
TopHat (version 1.3.3) [78]. TopHat incorporates the
Bowtie v0.12.7 algorithm to perform alignments. In brief,
TopHat initially removes a portion of reads based on the
quality of information accompanying each read and
maps qualified reads to the reference genome. The refer-
ence index was built using Bowtie with a fasta file for
the entire genome of zebrafish, which was downloaded
from UCSC (http://genome.ucsc.edu/). Parameters were
set by default, but the number of threads to align reads
was set at 6. TopHat aligned read files were then entered
into Cufflinks (version 1.2.1) software for further ana-
lyses, including transcript assembly, abundance estima-
tion, and differential expression and regulation testing in
RNA-Seq samples [79]. To calculate gene expression
intensity, read counts were normalized to the number of
fragments per kilobase of transcript per million mapped
reads (FPKM) according to the gene length and total
mapped reads [78]. Confidence intervals for estimates of
FPKM were calculated using a Bayesian inference
method [80]. The R package DEGseq was used to iden-
tify DEGs from RNA-Seq data. Genes with FPKM less
than 1 were removed from analyses. DEGs were charac-
terized according to the criterion of fold change (FC)
>2.0 and p-value <0.05.
RT-PCR
Real-time RT-PCR was performed to verify the expres-
sion of genes detected in mRNA-seq experiments involv-
ing Rpl11-deficient and MO control zebrafish embryos.
Reverse transcription was performed using the cDNA
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RT-PCR was performed using SYBR Green PCR Master
Mix (Fermentas) with a CFX-96 Real-time PCR system
according to the manufacturer’s instructions (Bio-Rad)
(Additional file 15: Table S10). PCR products were ana-
lyzed using agarose gel electrophoresis to identify bands
of expected sizes. Gene expression was calculated ac-
cording to the real-time PCR manual of Bio-Rad and
normalized to the expression of β-actin. Data were
represented as mean ± SD and One-way ANOVA was
performed for comparison between MO control and
Rpl11-deficient embryos.IPA analysis
Gene interaction networks and signaling pathways were
generated using Ingenuity Pathways Analysis (IPA) soft-
ware (http://www.ingenuity.com/) from Ingenuity® Sys-
tems. This software was used to analyze data from a
variety of experimental platforms and to provide accur-
ate biological insights into interactions between genes,
proteins, chemicals, pathways, cellular phenotypes, and
disease processes. Differentially expressed genes were
processed using DEGseq and screened according to the
criteria FC >2 and p-value <0.05. These genes were sub-
mitted to IPA for biological function, canonical path-
way, and interaction network analyses. Since the current
edition of IPA cannot accept and identify zebrafish gene
IDs, we matched these differentially expressed zebrafish
genes with their human homologs using the homolog
database HomoloGene, which was downloaded from
NCBI. After conversion to human homolog genes, these
homologs were submitted to IPA, sets of genes that
were enriched for a particular function or pathway were
identified, and enrichment ratios were calculated. To
determine the significance of enrichment in a particular
function, IPA calculates the significance value based on
the measure of involvement of the gene in the input
data set with its respective molecular functions and
signaling pathways [81]. The significance of networks
was calculated using Fisher’s exact test, and p-values were
executed using negative logarithmic transformation.Screening of differentially expressed hematological genes
Zebrafish gene sets associated with hematological systems
were identified by searching with the keywords “eryth-
roid,” “hematopoietic,” “globin,” and “hema” using the
AmiGO software of the Gene Ontology (GO) database
(http://www.geneontology.org/). Differentially expressed
genes (FC >2.0, p-value <0.05) detected by DEGseq were
mapped to this hematological gene set, which indicated
the differentially expressed hematological genes in our
data set. Mapping and drawing of the scatter diagrams
were accomplished using R scripts.Cluster analysis
Expression intensities of differentially expressed hema-
tological genes were used in cluster analyses. Gene
expression intensity was normalized using the equation
x
0
i ¼ xi−xx , where xi is the FPKM value and x is the
mean FPKM value of a gene calculated from two
samples. Average linkage hierarchical clustering was
performed in this study using Pearson distance as the
measure between genes and samples. Computation
and visualization were achieved using the heatmap
plus package in R.
Data access
Supporting data sets are available in the Gene Expression
Omnibus, with the accession number GSE45699. The fol-
lowing link has been created to allow review of record




Additional file 1: Table S1. RNA-seq reads mapping analysis.
Additional file 2: Table S2. All gene transcripts detected in Rpl11-
deficient and MO control zebrafish embryos using RNA-seq.
Additional file 3: Table S3. All DEGs in Rpl11-deficient zebrafish em-
bryos at 48 hpf. This table includes up- and downregulated genes in
Rpl11-deficient zebrafish embryos (fold change>1.5 or 2, p-value<0.05).
Additional file 4: Table S4. Specifically expressed genes in MO control
and Rpl11-deficient zebrafish embryos.
Additional file 5: GO enrichment of up- and downregulated genes in
Rpl11-deficient zebrafish embryos at 48 hpf. GO enrichment includes
three analytical aspects: biological process, molecular function, and cellu-
lar component. DEGs in Rpl11-deficient zebrafish embryos at 48 hpf
(FC >2, p-value <0.05) were included in this analysis. Blue labeled func-
tions are associated with DEGs in Rpl11-deficient zebrafish embryos. This
figure was generated using AmiGO software (http://www.geneontology.
org/). Figure S1, GO enrichment of upregulated genes in Rpl11-deficient
zebrafish embryos at 48 hpf. Figure S2, GO enrichment of downregulated
genes in Rpl11-deficient zebrafish embryos at 48 hpf.
Additional file 6: Table S5. Genes involved in GO enrichment of
up- and downregulated DEGs in Rpl11-deficient zebrafish embryos.
Additional file 7: Figure S3. qPCR analyses of human FTMT homologs in
Rpl11-deficient zebrafish embryos at 48 hpf. These genes were zgc:194125,
zgc:173594, and zgc:109934, which were specifically enriched in iron
metabolism-associated functions such as iron transport and cellular iron
homeostasis in GO analyses, and were upregualted in Rpl11-deficient
zebrafish embryos (Mean ± SD, one-way ANOVA, **P < 0.01, *<0.05, n = 3).
Gene expression in MO control samples was normalized to 1.
Additional file 8: Figure S4. Scatter plot of DEGs in Rpl11-deficient
zebrafish embryos at 48 hpf. DEGs affected by Rpl11 deficiency in zebrafish
embryos at 48 hpf are shown (FC >1.5, p-value <0.05), and affected
hematological genes (highlighted red) were further analyzed.
Additional file 9: Table S6. Affected hematological genes enriched in
GO items.
Additional file 10: Table S7. Disturbed signaling pathways in Rpl11-
deficient zebrafish embryos. This table includes up- and downregulated
signaling pathways in Rpl11-deficient zebrafish embryos at 48 hpf.
Additional file 11. Networks affected by Rpl11 deficiency in zebrafish
embryos at 48 hpf. Networks were generated using online IPA software,
Zhang et al. BMC Genomics 2013, 14:896 Page 12 of 14
http://www.biomedcentral.com/1471-2164/14/896and highly enriched networks were selected (Score > 20). Genes labeled
red and green were up- and downregulated, respectively. Figure S5 (A-C),
Upregulated networks affected by Rpl11 deficiency in zebrafish embryos
at 48 hpf. A, Networks of cellular function and maintenance, small molecule
biochemistry, and carbohydrate metabolism. B, Networks of cellular
development, cellular growth and proliferation, and connective tissue
development and function. C, Networks of cell death and survival,
connective tissue disorders, and immunological disease. Figure S6 (A-E),
Downregulated networks affected by Rpl11 deficiency in zebrafish
embryos at 48 hpf. A, Networks of developmental disorders, skeletal and
muscular disorders, and digestive system development and function. B,
Networks of cellular development, visual system development and function,
nervous system development and function, cellular growth and proliferation,
connective tissue development and function, neurological disease, and
tissue morphology. C, Networks of cell death and survival, cardiac pulmonary
embolism, and cardiovascular disease. D, Networks of cancer, cell cycle,
and tissue morphology. E, Networks of cell cycle, cell morphology, and
cell-to-cell signaling and interaction.
Additional file 12: Table S8. Genes involved in regulatory interacting
networks disturbed in Rpl11-deficiet zebrafish embryos.
Additional file 13: Table S9. Description of blood cell lineage markers.
Description of blood cell lineage markers, including cmyb, hoxb4a, tal1,
mpx, spi1, and ikzf1, were shown. Blood cell lineages, including
hematopoietic stem cells, granulocytes, myelocytes, and lymphoid
progenitors were detected in this study. Fold change represents FPKM in
Rpl11-deficient zebrafish embryos compared to that of MO control.
Additional file 14: Figure S7. RT-PCR analyses of changes in the
expression of globin genes in zebrafish embryos after Rpl11 knockdown. A,
RT-PCR analysis of changes in expression of globin genes in zebrafish
embryos after Rpl11 knockdown (Mean ± SD, one-way ANOVA, **P < 0.01,
*<0.05, n = 3). Gene expression in MO control samples was normalized
to 1; B, Description of globin genes detected in deep sequencing samples.
Additional file 15: Table S10. RT-PCR primers used in this study.Abbreviations
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